|
1
|
Sanz MA and Lo-Coco F: Modern approaches
to treating acute promyelocytic leukemia. J Clin Oncol. 29:495–503.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller WH Jr, Schipper HM, Lee JS, Singer
J and Waxman S: Mechanisms of action of arsenic trioxide. Cancer
Res. 62:3893–3903. 2002.PubMed/NCBI
|
|
3
|
Shen ZX, Chen GQ, Ni JH, et al: Use of
arsenic trioxide (As2O3) in the treatment of
acute promyelocytic leukemia (APL): II. Clinical efficacy and
pharmacokinetics in relapsed patients. Blood. 89:3354–3360.
1997.PubMed/NCBI
|
|
4
|
Niu C, Yan H, Yu T, et al: Studies on
treatment of acute promyelocytic leukemia with arsenic trioxide:
remission induction, follow-up, and molecular monitoring in 11
newly diagnosed and 47 relapsed acute promyelocytic leukemia
patients. Blood. 94:3315–3324. 1999.
|
|
5
|
Soignet SL, Maslak P, Wang ZG, et al:
Complete remission after treatment of acute promyelocytic leukemia
with arsenic trioxide. N Engl J Med. 339:1341–1348. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nagpal S, Na S and Rathnachalam R:
Noncalcemic actions of vitamin D receptor ligands. Endocr Rev.
26:662–687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deeb KK, Trump DL and Johnson CS: Vitamin
D signalling pathways in cancer: potential for anticancer
therapeutics. Nat Rev Cancer. 7:684–700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krishnan AV, Moreno J, Nonn L, et al:
Novel pathways that contribute to the anti-proliferative and
chemopreventive activities of calcitriol in prostate cancer. J
Steroid Biochem Mol Biol. 103:694–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abe E, Miyaura C, Sakagami H, et al:
Differentiation of mouse myeloid leukemia cells induced by 1
alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA.
78:4990–4994. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou JY, Norman AW, Chen DL, Sun GW,
Uskokovic M and Koeffler HP: 1,25-Dihydroxy-16-ene-23-yne-vitamin
D3 prolongs survival time of leukemic mice. Proc Natl
Acad Sci USA. 87:3929–3932. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCarthy DM, San Miguel JF, Freake HC, et
al: 1,25-dihydroxyvitamin D3 inhibits proliferation of
human promyelocytic leukaemia (HL60) cells and induces
monocyte-macrophage differentiation in HL60 and normal human bone
marrow cells. Leuk Res. 7:51–55. 1983.
|
|
12
|
Studzinski GP, Bhandal AK and Brelvi ZS:
Cell cycle sensitivity of HL-60 cells to the
differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin
D3. Cancer Res. 45:3898–3905. 1985.PubMed/NCBI
|
|
13
|
Muto A, Kizaki M, Yamato K, et al:
1,25-Dihydroxyvitamin D3 induces differentiation of a
retinoic acid-resistant acute promyelocytic leukemia cell line
(UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Blood. 93:2225–2233. 1999.PubMed/NCBI
|
|
14
|
Koeffler HP, Hirji K and Itri L:
1,25-Dihydroxyvitamin D3: in vivo and in vitro effects
on human preleukemic and leukemic cells. Cancer Treat Rep.
69:1399–1407. 1985.
|
|
15
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen GQ, Zhu J, Shi XG, et al: In vitro
studies on cellular and molecular mechanisms of arsenic trioxide
(As2O3) in the treatment of acute
promyelocytic leukemia: As2O3 induces NB4
cell apoptosis with downregulation of Bcl-2 expression and
modulation of PML-RAR alpha/PML proteins. Blood. 88:1052–1061.
1996.PubMed/NCBI
|
|
17
|
Jing Y, Dai J, Chalmers-Redman RM, Tatton
WG and Waxman S: Arsenic trioxide selectively induces acute
promyelocytic leukemia cell apoptosis via a hydrogen
peroxide-dependent pathway. Blood. 94:2102–2111. 1999.PubMed/NCBI
|
|
18
|
Yedjou C, Tchounwou P, Jenkins J and
McMurray R: Basic mechanisms of arsenic trioxide (ATO)-induced
apoptosis in human leukemia (HL-60) cells. J Hematol Oncol.
3:282010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vandewalle B, Wattez N and Lefebvre J:
Effects of vitamin D3 derivatives on growth,
differentiation and apoptosis in tumoral colonic HT 29 cells:
possible implication of intracellular calcium. Cancer Lett.
97:99–106. 1995.
|
|
20
|
Mathiasen IS, Sergeev IN, Bastholm L,
Elling F, Norman AW and Jäättelä M: Calcium and calpain as key
mediators of apoptosis-like death induced by vitamin D compounds in
breast cancer cells. J Biol Chem. 277:30738–30745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guzey M, Kitada S and Reed JC: Apoptosis
induction by 1alpha,25-dihydroxyvitamin D3 in prostate
cancer. Mol Cancer Ther. 1:667–677. 2002.PubMed/NCBI
|
|
22
|
Sergeev IN: Calcium as a mediator of
1,25-dihydroxyvitamin D3-induced apoptosis. J Steroid
Biochem Mol Biol. 89–90:419–425. 2004.PubMed/NCBI
|
|
23
|
Sergeev IN: 1,25-Dihydroxyvitamin
D3 induces Ca2+-mediated apoptosis in
adipocytes via activation of calpain and caspase-12. Biochem
Biophys Res Commun. 384:18–21. 2009.
|
|
24
|
Richard C, Mazo E, Cuadrado MA, et al:
Treatment of myelodysplastic syndrome with 1.25-dihydroxy-vitamin
D3. Am J Hematol. 23:175–178. 1986. View Article : Google Scholar
|
|
25
|
Scholz C, Wieder T, Stärck L, et al:
Arsenic trioxide triggers a regulated form of caspase-independent
necrotic cell death via the mitochondrial death pathway. Oncogene.
24:1904–1913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Florea AM, Splettstoesser F and Busselberg
D: Arsenic trioxide (As2O3) induced calcium
signals and cytotoxicity in two human cell lines: SY-5Y
neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl
Pharmacol. 220:292–301. 2007.
|
|
27
|
Günes DA, Florea AM, Splettstoesser F and
Büsselberg D: Co-application of arsenic trioxide
(As2O3) and cisplatin (CDDP) on human SY-5Y
neuroblastoma cells has differential effects on the intracellular
calcium concentration ([Ca2+]i) and cytotoxicity.
Neurotoxicology. 30:194–202. 2009.
|
|
28
|
Cai BZ, Meng FY, Zhu SL, et al: Arsenic
trioxide induces the apoptosis in bone marrow mesenchymal stem
cells by intracellular calcium signal and caspase-3 pathways.
Toxicol Lett. 193:173–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
